When a client asks us to manufacture DIM gummies, my focus lands on three engineering problems: heat, fat, and bitterness. DIM, or 3,3'-diindolylmethane, is the compound that forms from indole-3-carbinol when the body digests cruciferous vegetables, and supplement brands sell it for hormonal support. The pitch decks lead with bioavailability and market growth. Inside a production facility, the work starts with thermal limits.
1. Heat destroys DIM faster than you think
Thermal stability is a documented challenge for DIM. It degrades under prolonged heat and oxygen exposure. The problem in a gummy kitchen: the cooked sugar mass passes through temperatures near 80°C to dissolve sugars and stay fluid for depositing. Add DIM too early and you lose a measurable chunk. Add it too late and it doesn't disperse evenly.
What we do: We pre-disperse DIM into a lipid-based carrier that acts as a thermal shield. Then we cool the slurry below 65°C before adding that lipid-DIM complex. This keeps the active intact while we still get the flow we need for accurate fill weights.
If you're sourcing DIM gummies, put one question to your manufacturer: At what temperature do you add the DIM? If they can't give you a concrete number under 70°C, that's a red flag.
2. Water and oil don't mix, and that's a problem
DIM is lipophilic, meaning it dissolves in fat. Gummy bases are mostly water. Without deliberate engineering, the DIM migrates out over time. You end up with oily patches on the surface and uneven potency from one gummy to the next.
Many manufacturers throw in an emulsifier and hope for the best. That leads to cloudy gummies and short shelf lives.
Our approach: We use multi-phase emulsification with high-shear equipment. First, we dissolve DIM into MCT oil. Then we emulsify that into a water-based phase using modified starch and sunflower lecithin. This creates stable oil-in-water droplets small enough to stay suspended during gelation. The result is a clear, uniform gummy with no oil separation through the product's intended shelf life.
When you're vetting a manufacturer, don't accept "proprietary emulsifier" as an answer. Ask for the droplet size distribution. A manufacturer that can't produce that data is working blind, and the result is a gummy that sweats oil on the shelf.
3. The bitter truth about DIM
Purified DIM is nearly tasteless, but commercial DIM powder carries a mild bitterness, and some batches carry more. The sulfur note that gets blamed on DIM comes from glucosinolates in the original vegetables, not from the DIM molecule, which contains no sulfur. A gummy's flavor system relies on a careful balance of sweeteners and acids to cover the bitterness that is there. Too much acid weakens the gummy structure. Too little leaves an aftertaste consumers will notice immediately.
Our fix: We microencapsulate the DIM before it ever touches the cooking kettle. We use ethylcellulose and a natural flavor-masking system from citrus bioflavonoids. This creates a taste barrier that survives the entire cooking, depositing, and drying process.
For texture, we blend gelatin and pectin. Pectin alone releases bitterness too fast. Pure gelatin causes syneresis, where the gummy weeps liquid over time. The blend gives a firm but chewy bite that holds the encapsulated droplets in suspension.
DIM labels and the structure/function claim line
For DIM, the formulation challenges overlap with the marketing limits. Brands sell the molecule widely for hormone support, and that framing pushes them straight toward the line FDA draws between a structure/function claim and a disease claim. Under 21 U.S.C. 343(r)(6), a supplement label can say DIM supports healthy estrogen metabolism. It can't say DIM treats, cures, or prevents any condition. FDA requires brands to notify the agency of a structure/function claim no later than 30 days after first marketing, and the claim must be backed by substantiation.
The published evidence shows why that boundary matters. In its review of the ingredient, Memorial Sloan Kettering notes that a few studies suggest DIM may benefit certain prostate or cervical findings, but the evidence is limited and the effect on breast cancer risk is unknown. WebMD summarizes the state of the evidence the same way: the benefits are not well defined. A cautious brand writes its label around support language and keeps disease language away from the bottle.
A contract manufacturer can't write the label for you, but a good one will tell you where your claim text crosses that boundary before it goes to print. When you brief a DIM gummy, bring the finished label copy along with the formula. The claims review is part of the formulation conversation.
Why this matters
We don't drop DIM into a mold and call it done. Every step, from staged thermal processing to multi-phase emulsification to bitter-blocking encapsulation, is engineered around the molecule's weaknesses. It's the difference between a premium product that builds brand trust and a shelf-life failure that costs you money.
If you're considering a DIM gummy, or any lipophilic ingredient in a water-based format, don't accept a generic process. Demand specifics. Success here is measured in degrees Celsius and microns.
Ready to get the science right? Reach out to our team at KorNutra to discuss your next formulation challenge.
This post is for informational purposes only and does not constitute medical advice. KorNutra complies with all applicable FDA cGMP regulations.